BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38758583)

  • 1. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
    Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
    J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial.
    Parikh RB; Schriver E; Ferrell WJ; Wakim J; Williamson J; Khan N; Kopinsky M; Balachandran M; Gabriel PE; Schuchter LM; Patel MS; Shulman LN; Manz CR
    JCO Oncol Pract; 2023 Dec; 19(12):1143-1151. PubMed ID: 37816198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical Trial.
    Nipp RD; Horick NK; Qian CL; Knight HP; Kaslow-Zieve ER; Azoba CC; Elyze M; Landay SL; Kay PS; Ryan DP; Jackson VA; Greer JA; El-Jawahri A; Temel JS
    JAMA Oncol; 2022 Apr; 8(4):571-578. PubMed ID: 35142814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Daily Steps in the Treatment of Major Depressive Disorder: Secondary Analysis of a Randomized Controlled Trial of a 6-Month Internet-Based, Mindfulness-Based Cognitive Behavioral Therapy Intervention for Youth.
    Dang K; Ritvo P; Katz J; Gratzer D; Knyahnytska Y; Ortiz A; Walters C; Attia M; Gonzalez-Torres C; Lustig A; Daskalakis Z
    Interact J Med Res; 2023 Dec; 12():e46419. PubMed ID: 38064262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
    Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC
    JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Behaviorally Designed Gamification With a Social Support Partner to Increase Mobility After Hospital Discharge: A Randomized Clinical Trial.
    Greysen SR; Changolkar S; Small DS; Reale C; Rareshide CAL; Mercede A; Snider CK; Greysen HM; Trotta R; Halpern SD; Patel MS
    JAMA Netw Open; 2021 Mar; 4(3):e210952. PubMed ID: 33760089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HOPE Pilot Study: Harnessing Patient-Reported Outcomes and Biometric Data to Enhance Cancer Care.
    Wright AA; Raman N; Staples P; Schonholz S; Cronin A; Carlson K; Keating NL; Onnela JP
    JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Xu H; Mohamed M; Flannery M; Peppone L; Ramsdale E; Loh KP; Wells M; Jamieson L; Vogel VG; Hall BA; Mustian K; Mohile S; Culakova E
    JAMA Netw Open; 2023 Mar; 6(3):e234198. PubMed ID: 36947036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.
    Cella D; Grünwald V; Escudier B; Hammers HJ; George S; Nathan P; Grimm MO; Rini BI; Doan J; Ivanescu C; Paty J; Mekan S; Motzer RJ
    Lancet Oncol; 2019 Feb; 20(2):297-310. PubMed ID: 30658932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.
    Parikh RB; Ferrell W; Wakim J; Williamson J; Khan N; Kopinsky M; Balachandran M; Gabriel PE; Zhang Y; Schuchter LM; Shulman LN; Chen J; Patel MS; Manz CR
    BMJ Open; 2022 May; 12(5):e054675. PubMed ID: 35551088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a Self-Monitoring App in Supporting Physical Activity Maintenance Among Rural Canadians With Cancer After an Exercise Oncology Program: Cluster Randomized Controlled Trial.
    Ester M; Wagoner CW; Dreger J; Chen G; McDonough MH; McNeely ML; Culos-Reed SN
    JMIR Cancer; 2023 Sep; 9():e47187. PubMed ID: 37676714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data.
    Trojan A; Kühne C; Kiessling M; Schumacher J; Dröse S; Singer C; Jackisch C; Thomssen C; Kullak-Ublick GA
    JMIR Form Res; 2024 May; 8():e55917. PubMed ID: 38710048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.
    da Silva Lopes AM; Colomer-Lahiguera S; Darnac C; Giacomini S; Bugeia S; Gutknecht G; Spurrier-Bernard G; Cuendet M; Muet F; Aedo-Lopez V; Mederos N; Michielin O; Addeo A; Latifyan S; Eicher M
    JMIR Res Protoc; 2023 Oct; 12():e48386. PubMed ID: 37851498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
    Cella D; Motzer RJ; Suarez C; Blum SI; Ejzykowicz F; Hamilton M; Wallace JF; Simsek B; Zhang J; Ivanescu C; Apolo AB; Choueiri TK
    Lancet Oncol; 2022 Feb; 23(2):292-303. PubMed ID: 35032437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.
    Bakitas M; Lyons KD; Hegel MT; Balan S; Brokaw FC; Seville J; Hull JG; Li Z; Tosteson TD; Byock IR; Ahles TA
    JAMA; 2009 Aug; 302(7):741-9. PubMed ID: 19690306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an Oncology Nurse-Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial.
    Schenker Y; Althouse AD; Rosenzweig M; White DB; Chu E; Smith KJ; Resick JM; Belin S; Park SY; Smith TJ; Bakitas MA; Arnold RM
    JAMA Intern Med; 2021 Nov; 181(11):1451-1460. PubMed ID: 34515737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.